SCHEMBL6923366

SCHEMBL6923366

COc1ccc(C(C)C2(C(N)=O)CCCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.47
SLC6A3 Q01959 6/20 0.47
SLC6A2 P23975 4/20 0.44
LMNA P02545 2/20 0.44
CNR1 P21554 1/20 0.44
HTR2A P28223 1/20 0.44
HRH1 P35367 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
ALOX5 P09917 1/20 0.43
CTSK P43235 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
PARP1 P09874 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
PARP4 Q9UKK3 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6457544 1.00 SLC6A4 (0.47) SLC6A4SLC6A3SLC6A2LMNACNR1
SCHEMBL6458517 0.83 L3MBTL1 (0.52) SLC6A4SLC6A3SLC6A2PARP1
SCHEMBL6457801 0.83 L3MBTL1 (0.52) SLC6A4SLC6A3SLC6A2PARP1
SCHEMBL6925029 0.83 L3MBTL1 (0.52) SLC6A4SLC6A3SLC6A2PARP1
SCHEMBL5521100 0.83 ALOX5 (0.42) SLC6A4SLC6A3SLC6A2LMNAHRH3
SCHEMBL6922904 0.82 HSD11B1 (0.39) SLC6A3SLC6A2ALDH1A1
SCHEMBL517632 0.81 ALOX5 (0.41) SLC6A4SLC6A3SLC6A2LMNAALOX5
SCHEMBL6460103 0.77 TSHR (0.41) LMNAALDH1A1MEN1KMT2A
SCHEMBL639268 0.76 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2LMNACNR1
SCHEMBL2112323 0.72 LMNA (0.68) SLC6A4SLC6A3LMNACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed